Boehringer Ingelheim Archives -

FDA fast-tracks Lilly/Boehringer’s Jardiance in chronic kidney disease

https://pharmaphorum.com/news/fda-fast-tracks-lilly-boehringers-jardiance-in-chronic-kidney-disease/

Boehringer launches digital platform to raise awareness about trials

https://pharmaphorum.com/news/bi-launches-digital-platform-to-raise-awareness-about-trials/

Boehringer bags CHMP backing for Ofev in rare lung disease

https://pharmaphorum.com/news/boehringer-bags-chmp-backing-for-ofev-in-rare-lung-disease/

Lilly, Boehringer bag FDA okay for diabetes triple Trijardy XR

https://pharmaphorum.com/news/lilly-boehringer-bag-fda-okay-for-diabetes-triple-trijardy-xr/

BI buys rights to NASH-targeted tech from Singapore’s Enleofen

https://pharmaphorum.com/news/bi-buys-rights-to-nash-targeted-tech-from-singapores-enleofen/

Boehringer cleared to manufacture BeiGene’s cancer drug for Chinese market

https://pharmaphorum.com/news/boehringer-gets-clearance-to-manufacture/

Boehringer, Lilly start acute heart failure trial with Jardiance

https://pharmaphorum.com/news/boehringer-lilly-start-acute-heart-failure-trial-with-jardiance/

Boehringer Ingelheim to present data at RAS Summit Europe

https://pharmaphorum.com/partner-content/boehringer-ingelheim-to-present-data-at-ras-summit-europe/

Lilly and Boehringer rejig diabetes alliance as Jardiance soars

https://pharmaphorum.com/news/lilly-and-boehringer-rejig-diabetes-alliance-as-jardiance-soars/

Search